Got $10,000? This Under‑the‑Radar Medical Device Giant Could Be a Millionaire Maker by 2036.

Intuitive Surgical (NASDAQ: ISRG) has a immense 64 price-to-earnings ratio. Medtronic (NYSE: MDT), a rival successful the aesculapian instrumentality niche, has a P/E ratio of 26. There's an accidental present for semipermanent investors who deliberation successful decades, not days.

The large communicative astir Intuitive Surgical is that it is simply a person successful surgical robotics acknowledgment to its da Vinci surgical systems. At the extremity of 2025, it had 11,106 da Vinci systems installed, up 12% twelvemonth implicit year. That said, the fig of surgeries performed by da Vinci systems roseate 18% twelvemonth implicit year. Very clearly, determination is worldly request for the company's robots successful the aesculapian assemblage and among patients.

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

The key, however, is that lone astir 25% of the company's gross travel from income of caller robots. The remainder is derived from what amounts to parts and services. These annuity-like income streams are the existent flywheel of the business, and they turn successful size with each caller da Vinci strategy sold.

That said, Intuitive Surgical banal is alternatively costly astatine the moment. Medtronic trades astatine a overmuch much charismatic valuation. And, here's the important part, Medtronic has its ain surgical robot called Hugo. Hugo isn't arsenic acold on arsenic the da Vinci system, developmentally, but it is catching up. And that means determination could beryllium a important maturation accidental up for Medtronic.

However, there's much to Medtronic than conscionable the Hugo surgical robot. It is 1 of the world's largest and astir diversified aesculapian instrumentality companies. So there's a coagulated halfway supporting the propulsion into surgical robotics. And there's nary crushed to judge that it can't find a abstraction beside Intuitive Surgical successful the fast-growing surgical robotics business. Notably, the FDA approved Hugo for usage successful the United States successful precocious 2025.

As noted, Medtronic's concern is much diversified than Intuitive Surgical's. However, you besides get thing else. Unlike Intuitive Surgical, Medtronic pays a dividend, offering an charismatic 2.9% yield. And it is closing successful connected Dividend King status, with conscionable a mates of years to spell earlier its yearly dividend summation streak hits 50 years.

A $10,000 concern successful Medtronic volition bargain astir 100 shares of the stock. As it builds retired its Hugo surgical system's installed basal implicit the adjacent 10 years, Wall Street could commencement to spot a higher valuation connected the stock. While it whitethorn not get the affluent valuation afforded to Intuitive Surgical, a rising banal terms would mean buying it contiguous gets you some income and growth.